TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00452	Threonine and 2-Oxobutanoate Degradation	0.00387219212948053	-5.55393449058177	9	3	0.0789473684210526	38	978	5096,594,5095	PCCB,BCKDHB,PCCA
SMP00522	3-hydroxyisobutyric aciduria	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00524	Isovaleric acidemia	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00238	Isovaleric Aciduria	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00199	Maple Syrup Urine Disease	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00236	Propionic Acidemia	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00200	Methylmalonic Aciduria	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00140	3-Methylglutaconic Aciduria Type III	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00139	3-Methylglutaconic Aciduria Type I	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00032	Valine- Leucine and Isoleucine Degradation	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00173	Beta-Ketothiolase Deficiency	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00141	3-Methylglutaconic Aciduria Type IV	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.00473353150844217	-5.35308373593873	30	5	0.131578947368421	38	978	5096,217,594,5095,56922	PCCB,ALDH2,BCKDHB,PCCA,MCCC1
SMP00127	Glucose-Alanine Cycle	0.0355165789649999	-3.33775567841885	8	2	0.0526315789473684	38	978	84706,6509	GPT2,SLC1A4
SMP00263	Cilostazol Action Pathway	0.0388548057260572	-3.24792351030622	1	1	0.0263157894736842	38	978	5144	PDE4D
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	0.0388548057260572	-3.24792351030622	1	1	0.0263157894736842	38	978	5144	PDE4D
SMP00582	Joubert syndrome	0.0443787183400565	-3.1149952411183	21	3	0.0789473684210526	38	978	23236,5305,30849	PLCB1,PIP4K2A,PIK3R4
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.0443787183400565	-3.1149952411183	21	3	0.0789473684210526	38	978	23236,5305,30849	PLCB1,PIP4K2A,PIK3R4
SMP00351	GABA-Transaminase Deficiency	0.0445578323466008	-3.11096733026895	9	2	0.0526315789473684	38	978	217,2571	ALDH2,GAD1
SMP00492	Ureidopropionase deficiency	0.0445578323466008	-3.11096733026895	9	2	0.0526315789473684	38	978	217,2571	ALDH2,GAD1
SMP00493	Carnosinuria- carnosinemia	0.0445578323466008	-3.11096733026895	9	2	0.0526315789473684	38	978	217,2571	ALDH2,GAD1
SMP00007	Beta-Alanine Metabolism	0.0445578323466008	-3.11096733026895	9	2	0.0526315789473684	38	978	217,2571	ALDH2,GAD1
SMP00004	Glycine and Serine Metabolism	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00244	Sarcosinemia	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00223	Non Ketotic Hyperglycinemia	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00485	Hyperglycinemia- non-ketotic	0.0759411890692654	-2.57779606629125	26	3	0.0789473684210526	38	978	217,29968,26227	ALDH2,PSAT1,PHGDH
SMP00198	Malonic Aciduria	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	5096,5095	PCCB,PCCA
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	5096,5095	PCCB,PCCA
SMP00067	Aspartate Metabolism	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	440,2571	ASNS,GAD1
SMP00175	Canavan Disease	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	440,2571	ASNS,GAD1
SMP00192	Hypoacetylaspartia	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	440,2571	ASNS,GAD1
SMP00502	Malonyl-coa decarboxylase deficiency	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	5096,5095	PCCB,PCCA
SMP00016	Propanoate Metabolism	0.0997306754721719	-2.30528197158245	14	2	0.0526315789473684	38	978	5096,5095	PCCB,PCCA
SMP00420	Bevacizumab Action Pathway	0.112204277791713	-2.18743416013448	3	1	0.0263157894736842	38	978	7422	VEGFA
SMP00609	Mercaptopurine Metabolism Pathway	0.11233018046533	-2.18631270476599	15	2	0.0526315789473684	38	978	8833,10057	GMPS,ABCC5
SMP00442	Etoposide Action Pathway	0.152312690861368	-1.88181969450686	18	2	0.0526315789473684	38	978	51726,5742	DNAJB11,PTGS1
SMP00601	Etoposide Metabolism Pathway	0.152312690861368	-1.88181969450686	18	2	0.0526315789473684	38	978	51726,5742	DNAJB11,PTGS1
SMP00021	Taurine and Hypotaurine Metabolism	0.180092394209042	-1.71428525862456	5	1	0.0263157894736842	38	978	2571	GAD1
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	0.180092394209042	-1.71428525862456	5	1	0.0263157894736842	38	978	622	BDH1
SMP00071	Ketone Body Metabolism	0.180092394209042	-1.71428525862456	5	1	0.0263157894736842	38	978	622	BDH1
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	8833,2571	GMPS,GAD1
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	8833,2571	GMPS,GAD1
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	8833,2571	GMPS,GAD1
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	8833,2571	GMPS,GAD1
SMP00590	Ibuprofen Metabolism Pathway	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	51726,5742	DNAJB11,PTGS1
SMP00385	Homocarnosinosis	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	8833,2571	GMPS,GAD1
SMP00072	Glutamate Metabolism	0.209121593813069	-1.56483940761141	22	2	0.0526315789473684	38	978	8833,2571	GMPS,GAD1
SMP00445	Spermidine and Spermine Biosynthesis	0.212113451783933	-1.55063399752757	6	1	0.0263157894736842	38	978	4144	MAT2A
SMP00449	Ethanol Degradation	0.242915600788521	-1.41504121782973	7	1	0.0263157894736842	38	978	217	ALDH2
SMP00627	Citalopram Metabolism Pathway	0.242915600788521	-1.41504121782973	7	1	0.0263157894736842	38	978	4129	MAOB
SMP00682	Leucine Stimulation on Insulin Signaling	0.242915600788521	-1.41504121782973	7	1	0.0263157894736842	38	978	8140	SLC7A5
SMP00041	Sulfate/Sulfite Metabolism	0.242915600788521	-1.41504121782973	7	1	0.0263157894736842	38	978	6820	SULT2B1
SMP00532	Sulfite oxidase deficiency	0.242915600788521	-1.41504121782973	7	1	0.0263157894736842	38	978	6820	SULT2B1
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00030	Oxidation of Branched Chain Fatty Acids	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	217	ALDH2
SMP00005	Pterine Biosynthesis	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00490	Segawa syndrome	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00491	Sepiapterin reductase deficiency	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00486	Dopa-responsive dystonia	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	2644	GCHFR
SMP00123	Betaine Metabolism	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	4144	MAT2A
SMP00644	Celecoxib Metabolism Pathway	0.272544032477651	-1.29995509085867	8	1	0.0263157894736842	38	978	5742	PTGS1
SMP00428	Mercaptopurine Action Pathway	0.273921118547539	-1.29491510255455	47	3	0.0789473684210526	38	978	8833,5144,10057	GMPS,PDE4D,ABCC5
SMP00430	Thioguanine Action Pathway	0.273921118547539	-1.29491510255455	47	3	0.0789473684210526	38	978	8833,5144,10057	GMPS,PDE4D,ABCC5
SMP00427	Azathioprine Action Pathway	0.273921118547539	-1.29491510255455	47	3	0.0789473684210526	38	978	8833,5144,10057	GMPS,PDE4D,ABCC5
SMP00640	Acetaminophen Metabolism Pathway	0.297397721875047	-1.21268490512312	28	2	0.0526315789473684	38	978	51726,10057	DNAJB11,ABCC5
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.301042307494516	-1.20050446765021	9	1	0.0263157894736842	38	978	833	CARS
SMP00013	Cysteine Metabolism	0.301042307494516	-1.20050446765021	9	1	0.0263157894736842	38	978	833	CARS
SMP00722	Cystinosis- ocular nonnephropathic	0.301042307494516	-1.20050446765021	9	1	0.0263157894736842	38	978	833	CARS
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.301042307494516	-1.20050446765021	9	1	0.0263157894736842	38	978	3363	HTR7
SMP00635	Valproic Acid Metabolism Pathway	0.354814818355012	-1.03615926404397	11	1	0.0263157894736842	38	978	1962	EHHADH
SMP00009	Ammonia Recycling	0.354814818355012	-1.03615926404397	11	1	0.0263157894736842	38	978	440	ASNS
SMP00029	Selenoamino Acid Metabolism	0.354814818355012	-1.03615926404397	11	1	0.0263157894736842	38	978	4144	MAT2A
SMP00424	Citalopram Action Pathway	0.355921103157283	-1.03304619303624	32	2	0.0526315789473684	38	978	483,4129	ATP1B3,MAOB
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.355921103157283	-1.03304619303624	32	2	0.0526315789473684	38	978	5599,2534	MAPK8,FYN
SMP00068	Androgen and Estrogen Metabolism	0.380168527665049	-0.967140630720645	12	1	0.0263157894736842	38	978	6820	SULT2B1
SMP00565	Aromatase deficiency	0.380168527665049	-0.967140630720645	12	1	0.0263157894736842	38	978	6820	SULT2B1
SMP00458	Lactose Intolerance	0.380168527665049	-0.967140630720645	12	1	0.0263157894736842	38	978	483	ATP1B3
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	0.380168527665049	-0.967140630720645	12	1	0.0263157894736842	38	978	6820	SULT2B1
SMP00457	Lactose Degradation	0.380168527665049	-0.967140630720645	12	1	0.0263157894736842	38	978	483	ATP1B3
SMP00078	Chlorothiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00088	Bumetanide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00115	Furosemide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00105	Metolazone Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00197	Lysinuric Protein Intolerance	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00245	Glucose Transporter Defect (SGLT2)	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00090	Bendroflumethiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00100	Hydrochlorothiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00583	Blue diaper syndrome	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00135	Eplerenone Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00483	Kidney Function	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00081	Methyclothiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00108	Hydroflumethiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00723	Cystinuria	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00134	Spironolactone Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00118	Torsemide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00189	Hartnup Disorder	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00133	Amiloride Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00184	Glucose Transporter Defect (SGLT2)	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00097	Ethacrynic Acid Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00091	Quinethazone Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00585	Lysinuric protein intolerance (LPI)	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00132	Triamterene Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00103	Cyclothiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00110	Indapamide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00193	Iminoglycinuria	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00121	Trichlormethiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00080	Polythiazide Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00122	Chlorthalidone Action Pathway	0.384635906456134	-0.95545808966491	34	2	0.0526315789473684	38	978	483,8140	ATP1B3,SLC7A5
SMP00467	Trehalose Degradation	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	483	ATP1B3
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	6509	SLC1A4
SMP00003	Argininosuccinic Aciduria	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	6509	SLC1A4
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	6509	SLC1A4
SMP00357	Argininemia	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	6509	SLC1A4
SMP00001	Citrullinemia Type I	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	6509	SLC1A4
SMP00059	Urea Cycle	0.404551132167661	-0.904977142146959	13	1	0.0263157894736842	38	978	6509	SLC1A4
SMP00203	Molybdenum Cofactor Deficiency	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00167	Adenylosuccinate Lyase Deficiency	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00537	Myoadenylate deaminase deficiency	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00050	Purine Metabolism	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00144	Adenosine Deaminase Deficiency	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00536	Mitochondrial DNA depletion syndrome	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00512	Xanthinuria type I	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00513	Xanthinuria type II	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00168	AICA-Ribosiduria	0.426717907204997	-0.851632122935701	37	2	0.0526315789473684	38	978	8833,5144	GMPS,PDE4D
SMP00648	Sorafenib Metabolism Pathway	0.427998859606122	-0.848634747875568	14	1	0.0263157894736842	38	978	51726	DNAJB11
SMP00044	Histidine Metabolism	0.427998859606122	-0.848634747875568	14	1	0.0263157894736842	38	978	217	ALDH2
SMP00191	Histidinemia	0.427998859606122	-0.848634747875568	14	1	0.0263157894736842	38	978	217	ALDH2
SMP00622	Morphine Metabolism Pathway	0.450546622402337	-0.797293716939251	15	1	0.0263157894736842	38	978	51726	DNAJB11
SMP00040	Glycolysis	0.450546622402337	-0.797293716939251	15	1	0.0263157894736842	38	978	3099	HK2
SMP00531	Glycogenosis- Type VII. Tarui disease	0.450546622402337	-0.797293716939251	15	1	0.0263157894736842	38	978	3099	HK2
SMP00572	Fanconi-bickel syndrome	0.450546622402337	-0.797293716939251	15	1	0.0263157894736842	38	978	3099	HK2
SMP00406	Morphine Action Pathway	0.467363609412443	-0.760647717391437	40	2	0.0526315789473684	38	978	51726,483	DNAJB11,ATP1B3
SMP00555	Glycogenosis- Type VI. Hers disease	0.472228064094612	-0.750293223452529	16	1	0.0263157894736842	38	978	3099	HK2
SMP00058	Starch and Sucrose Metabolism	0.472228064094612	-0.750293223452529	16	1	0.0263157894736842	38	978	3099	HK2
SMP00557	Sucrase-isomaltase deficiency	0.472228064094612	-0.750293223452529	16	1	0.0263157894736842	38	978	3099	HK2
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.472228064094612	-0.750293223452529	16	1	0.0263157894736842	38	978	3099	HK2
SMP00552	Glycogen synthetase deficiency	0.472228064094612	-0.750293223452529	16	1	0.0263157894736842	38	978	3099	HK2
SMP00317	Familial Hypercholanemia (FHCA)	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00316	Zellweger Syndrome	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00314	Congenital Bile Acid Synthesis Defect Type II	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00035	Bile Acid Biosynthesis	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00650	Doxorubicin Metabolism Pathway	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	874	CBR3
SMP00318	Congenital Bile Acid Synthesis Defect Type III	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00720	27-Hydroxylase Deficiency	0.493075604182403	-0.707092761357616	17	1	0.0263157894736842	38	978	8309	ACOX2
SMP00725	Fructose intolerance- hereditary	0.513120481437146	-0.667244604783239	18	1	0.0263157894736842	38	978	2762	GMDS
SMP00561	Fructosuria	0.513120481437146	-0.667244604783239	18	1	0.0263157894736842	38	978	2762	GMDS
SMP00064	Fructose and Mannose Degradation	0.513120481437146	-0.667244604783239	18	1	0.0263157894736842	38	978	2762	GMDS
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00063	Tryptophan Metabolism	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	217	ALDH2
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00221	Methionine Adenosyltransferase Deficiency	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00177	Cystathionine Beta-Synthase Deficiency	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00341	Hypermethioninemia	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00033	Methionine Metabolism	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00222	Glycine N-methyltransferase Deficiency	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.532392795714206	-0.630373724269102	19	1	0.0263157894736842	38	978	4144	MAT2A
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00207	Prolidase Deficiency (PD)	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00360	Hyperprolinemia Type II	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00208	Prolinemia Type II	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00361	Hyperprolinemia Type I	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00020	Arginine and Proline Metabolism	0.550921548335456	-0.596162860482703	20	1	0.0263157894736842	38	978	4842	NOS1
SMP00086	Ibuprofen Action Pathway	0.555549565568857	-0.587797446936302	47	2	0.0526315789473684	38	978	51726,5742	DNAJB11,PTGS1
SMP00525	Fabry disease	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	259230	SGMS1
SMP00011	Inositol Metabolism	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	30849	PIK3R4
SMP00526	Krabbe disease	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	259230	SGMS1
SMP00349	Gaucher Disease	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	259230	SGMS1
SMP00433	Irinotecan Action Pathway	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	51726	DNAJB11
SMP00600	Irinotecan Metabolism Pathway	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	51726	DNAJB11
SMP00034	Sphingolipid Metabolism	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	259230	SGMS1
SMP00347	Metachromatic Leukodystrophy (MLD)	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	259230	SGMS1
SMP00348	Globoid Cell Leukodystrophy	0.568734681074382	-0.564341243454426	21	1	0.0263157894736842	38	978	259230	SGMS1
SMP00128	Gluconeogenesis	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00060	Pyruvate Metabolism	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	217	ALDH2
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00574	Glycogenosis- Type IC	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	217	ALDH2
SMP00563	Triosephosphate isomerase	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00562	Fructose-1-6-diphosphatase deficiency	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00196	Leigh Syndrome	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	217	ALDH2
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	217	ALDH2
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00558	Primary hyperoxaluria II- PH2	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	217	ALDH2
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00573	Glycogenosis- Type IB	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	3099	HK2
SMP00559	Pyruvate kinase deficiency	0.585859113800959	-0.53467593844556	22	1	0.0263157894736842	38	978	217	ALDH2
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.588373163233321	-0.53039390102764	77	3	0.0789473684210526	38	978	51726,483,23236	DNAJB11,ATP1B3,PLCB1
SMP00429	Disulfiram Action Pathway	0.618144665988781	-0.48103276155813	24	1	0.0263157894736842	38	978	217	ALDH2
SMP00674	Anileridine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00411	Hydrocodone Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00689	Dihydromorphine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00687	Naltrexone Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00675	Diphenoxylate Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00417	Sufentanil Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00686	Pentazocine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00404	Ropivacaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00425	Escitalopram Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00679	3-Methylthiofentanyl Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00681	Ethylmorphine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00684	Buprenorphine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00672	Propoxyphene Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00690	Ketobemidone  Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00392	Benzocaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00410	Hydromorphone Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00399	Mepivacaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00678	Methadyl Acetate Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00416	Remifentanil Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00671	Tramadol Action Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00393	Bupivacaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00396	Dibucaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00415	Fentanyl Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00673	Levorphanol Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00401	Prilocaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00685	Alvimopan Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00400	Oxybuprocaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00394	Chloroprocaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00414	Carfentanil Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00397	Levobupivacaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00676	Dezocine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00413	Alfentanil Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00395	Cocaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00412	Oxymorphone Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00688	Naloxone Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00403	Proparacaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00677	Levomethadyl Acetate Action Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00683	Levallorphan Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00402	Procaine Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00680	Dimethylthiambutene Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00409	Oxycodone Action Pathway	0.647974475783749	-0.433903972628248	26	1	0.0263157894736842	38	978	483	ATP1B3
SMP00691	Nalbuphine Action Pathway	0.662025914776443	-0.412450577623341	27	1	0.0263157894736842	38	978	483	ATP1B3
SMP00423	Desipramine Action Pathway	0.662025914776443	-0.412450577623341	27	1	0.0263157894736842	38	978	483	ATP1B3
SMP00306	Pindolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00323	Quinidine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00660	Sotalol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00379	Nifedipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00325	Disopyramide Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00669	Practolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00667	Metipranolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00380	Nimodipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00381	Nisoldipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00659	Timolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00661	Epinephrine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00366	Nebivolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00377	Felodipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00296	Acebutolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00305	Penbutolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00663	Isoprenaline Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00658	Carteolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00657	Bopindolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00664	Arbutamine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00588	Muscle/Heart Contraction	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00298	Atenolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00304	Oxprenolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00332	Ibutilide Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00665	Amiodarone Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00378	Isradipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00670	Bupranolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00303	Nadolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00297	Alprenolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00331	Flecainide Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00359	Diltiazem Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00375	Verapamil Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00382	Nitrendipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00662	Dobutamine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00329	Mexiletine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00302	Metoprolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00300	Bisoprolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00376	Amlodipine Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00301	Esmolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00299	Betaxolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00330	Tocainide Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00307	Propranolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00666	Levobunolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00668	Bevantolol Action Pathway	0.663494710198313	-0.410234397813904	57	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00368	Labetalol Action Pathway	0.673095182578102	-0.395868529058231	58	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00367	Carvedilol Action Pathway	0.673095182578102	-0.395868529058231	58	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00706	Tenoxicam Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00693	Antrafenine Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00102	Bromfenac Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00699	Lumiracoxib Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00098	Ketorolac Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00106	Meloxicam Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00707	Salsalate Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00085	Ketoprofen Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00692	Antipyrine Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00353	Leukotriene C4 Synthesis Deficiency	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00700	Lornoxicam Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00701	Phenylbutazone Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	483	ATP1B3
SMP00094	Sulindac Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00114	Nabumetone Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00109	Mefenamic Acid Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00113	Oxaprozin Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00702	Nepafenac Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00698	Magnesium salicylate Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00289	Diflunisal Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00708	Salicylate-sodium Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00077	Piroxicam Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00083	Acetylsalicylic Acid Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00710	Acetaminophen  Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00697	Flurbiprofen Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00084	Etodolac Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00075	Arachidonic Acid Metabolism	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00696	Fenoprofen Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00703	Trisalicylate-choline Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00709	Salicylic Acid Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00093	Diclofenac Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00695	Etoricoxib Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00101	Suprofen Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00704	Tolmetin Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00694	Carprofen Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00705	Tiaprofenic Acid Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00087	Rofecoxib Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00116	Valdecoxib Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00120	Naproxen Action Pathway	0.675530662662505	-0.392256730069525	28	1	0.0263157894736842	38	978	5742	PTGS1
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.68248182292582	-0.382019385353411	59	2	0.0526315789473684	38	978	483,23236	ATP1B3,PLCB1
SMP00405	Codeine Action Pathway	0.68850943615625	-0.373226255524266	29	1	0.0263157894736842	38	978	483	ATP1B3
SMP00104	Indomethacin Action Pathway	0.68850943615625	-0.373226255524266	29	1	0.0263157894736842	38	978	5742	PTGS1
SMP00407	Heroin Action Pathway	0.68850943615625	-0.373226255524266	29	1	0.0263157894736842	38	978	483	ATP1B3
SMP00422	Imipramine Action Pathway	0.700982187923592	-0.355272801794494	30	1	0.0263157894736842	38	978	483	ATP1B3
SMP00426	Fluoxetine Action Pathway	0.71296813397743	-0.338318552445378	31	1	0.0263157894736842	38	978	483	ATP1B3
SMP00431	Nicotine Action Pathway	0.724485780134752	-0.322293144557214	32	1	0.0263157894736842	38	978	483	ATP1B3
SMP00408	Methadone Action Pathway	0.724485780134752	-0.322293144557214	32	1	0.0263157894736842	38	978	483	ATP1B3
SMP00096	Celecoxib Action Pathway	0.746186797259216	-0.292779311652042	34	1	0.0263157894736842	38	978	5742	PTGS1
SMP00336	Vitamin A Deficiency	0.756403854149139	-0.279179846825915	35	1	0.0263157894736842	38	978	51726	DNAJB11
SMP00074	Retinol Metabolism	0.756403854149139	-0.279179846825915	35	1	0.0263157894736842	38	978	51726	DNAJB11
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.784710448167167	-0.24244048508178	38	1	0.0263157894736842	38	978	5599	MAPK8
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.784710448167167	-0.24244048508178	38	1	0.0263157894736842	38	978	5599	MAPK8
SMP00654	Warburg Effect	0.83887495124777	-0.175693628619938	45	1	0.0263157894736842	38	978	3099	HK2
SMP00455	Homocysteine Degradation	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00612	Esomeprazole Metabolism Pathway	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00616	Rabeprazole Metabolism Pathway	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00613	Omeprazole Metabolism Pathway	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00614	Lansoprazole Metabolism Pathway	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00615	Pantoprazole Metabolism Pathway	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00456	Fatty Acid Biosynthesis	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00514	Gamma-cystathionase deficiency (CTH)	0.999999999998752	-1.24785468416655e-12	2	0	0	38	978
SMP00631	Prednisone Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00265	Abciximab Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00476	Trastuzumab Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00593	Enalapril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00732	Temocapril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00632	Prednisolone Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00473	Gefitinib Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00261	Ticlopidine Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00595	Moexipril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00475	Panitumumab Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00647	Thioguanine Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00474	Cetuximab Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00591	Benazepril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00597	Ramipril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00267	Tirofiban Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00596	Quinapril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00617	Cimetidine Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00421	Vatalanib Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00592	Cilazapril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00036	D-Arginine and D-Ornithine Metabolism	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00470	Fluorouracil Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00611	Ticlopidine Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00599	Trandolapril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00594	Fosinopril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00598	Spirapril Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00440	Prednisone Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00638	Levomethadyl Acetate Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00441	Prednisolone Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00266	Eptifibatide Action Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00608	Fluorouracil Metabolism Pathway	0.999999999999942	-5.79050696281058e-14	1	0	0	38	978
SMP00653	Rosiglitazone Metabolism Pathway	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00126	Phenylacetate Metabolism	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00619	Felodipine Metabolism Pathway	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00464	Vitamin K Metabolism	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00626	Desipramine Metabolism Pathway	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00124	Glycerol Phosphate Shuttle	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00459	Pyruvaldehyde Degradation	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00174	Biotinidase Deficiency	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00472	Erlotinib Action Pathway	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00066	Biotin Metabolism	1.00000000000023	2.33350841362563e-13	3	0	0	38	978
SMP00153	Quinapril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00623	Heroin Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00165	Valsartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00602	Teniposide Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00150	Lisinopril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00633	Felbamate Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00164	Telmisartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00076	Thiamine Metabolism	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00651	Artemether Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00145	Benazepril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00443	Teniposide Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00733	Temocapril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00621	Codeine Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00450	Phytanic Acid Peroxisomal Oxidation	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00152	Perindopril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00012	Catecholamine Biosynthesis	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00149	Fosinopril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00065	Ubiquinone Biosynthesis	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00163	Olmesartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00629	Adefovir Dipivoxil Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00154	Ramipril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00497	Tyrosine hydroxylase deficiency	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00479	Plasmalogen Synthesis	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00148	Enalapril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00162	Losartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00451	Refsum Disease	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00155	Rescinnamine Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00161	Irbesartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00639	Clomipramine Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00146	Captopril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00160	Forasartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00129	Malate-Aspartate Shuttle	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00587	Angiotensin Metabolism	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00159	Eprosartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00147	Cilazapril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00630	Tenofovir Metabolism Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00156	Spirapril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00151	Moexipril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00158	Candesartan Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00157	Trandolapril Action Pathway	1.00000000000031	3.09728684824814e-13	4	0	0	38	978
SMP00055	Alanine Metabolism	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00070	Riboflavin Metabolism	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00468	Degradation of Superoxides	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00352	Primary Hyperoxaluria Type I	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00516	Adrenoleukodystrophy- X-linked	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00454	Repaglinide Action Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00350	Pyruvate Carboxylase Deficiency	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00641	Doxepin Metabolism Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00453	Nateglinide Action Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00469	Capecitabine Action Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00460	Glibenclamide Action Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00607	Capecitabine Metabolism Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00313	Lactic Acidemia	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00643	Pancreas Function	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00503	Hypophosphatasia	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00017	Vitamin B6 Metabolism	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00517	Carnitine-acylcarnitine translocase deficiency	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00310	Corticotropin Activation of Cortisol Production	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00461	Gliclazide Action Pathway	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00465	Carnitine Synthesis	1.00000000000034	3.4000457983024e-13	5	0	0	38	978
SMP00054	Fatty Acid Elongation In Mitochondria	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00634	Carbamazepine Metabolism Pathway	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00434	Paclitaxel Action Pathway	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00322	Vasopressin Regulation of Water Homeostasis	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00637	Tramadol Metabolism Pathway	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00435	Docetaxel Action Pathway	1.00000000000069	6.86795836415145e-13	7	0	0	38	978
SMP00496	Galactosemia III	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00495	Galactosemia II (GALK)	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00010	Nucleotide Sugars Metabolism	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00605	Ifosfamide Metabolism Pathway	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00028	Caffeine Metabolism	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00073	Butyrate Metabolism	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00448	Ifosfamide Action Pathway	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00642	Nevirapine Metabolism Pathway	1.00000000000091	9.1272823386648e-13	8	0	0	38	978
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	1.00000000000094	9.39199346360535e-13	12	0	0	38	978
SMP00053	Folate Metabolism	1.00000000000094	9.39199346360535e-13	12	0	0	38	978
SMP00432	Methotrexate Action Pathway	1.00000000000094	9.39199346360535e-13	12	0	0	38	978
SMP00724	Folate malabsorption- hereditary	1.00000000000094	9.39199346360535e-13	12	0	0	38	978
SMP00228	Pantoprazole Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00580	GLUT-1 deficiency syndrome	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00232	Cimetidine Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00444	Lactose Synthesis	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00610	Clopidogrel Metabolism Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00225	Esomeprazole Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00716	Thyroid hormone synthesis	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00604	Cyclophosphamide Metabolism Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00230	Ranitidine Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00734	Roxatidine acetate Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00226	Omeprazole Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00735	Metiamide Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00260	Clopidogrel Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00736	Betazole Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00589	Gastric Acid Production	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00229	Rabeprazole Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00233	Nizatidine Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00466	Transfer of Acetyl Groups into Mitochondria	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00227	Lansoprazole Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00231	Famotidine Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00246	Pirenzepine Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00579	Congenital disorder of glycosylation CDG-IId	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00447	Cyclophosphamide Action Pathway	1.00000000000103	1.02862297054308e-12	9	0	0	38	978
SMP00646	Fluoxetine Metabolism Pathway	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00478	Nucleotide Excision Repair 	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00636	Venlafaxine Metabolism Pathway	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00628	Nicotine Metabolism Pathway	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00308	Dopamine Activation of Neurological Reward System	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00625	Imipramine Metabolism Pathway	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00027	Pantothenate and CoA Biosynthesis	1.00000000000118	1.17961951900373e-12	6	0	0	38	978
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00437	Vincristine Action Pathway	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00606	Tamoxifen Metabolism Pathway	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00438	Vindesine Action Pathway	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00471	Tamoxifen Action Pathway	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00624	Methadone Metabolism Pathway	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	1.00000000000128	1.27928640307463e-12	10	0	0	38	978
SMP00436	Vinblastine Action Pathway	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00015	Glutathione Metabolism	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00500	5-oxoprolinase deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00187	Glycerol Kinase Deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00717	Apparent mineralocorticoid excess syndrome	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00370	Tyrosinemia Type 3 (TYRO3)	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00391	Insulin Signalling	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00008	Phenylalanine and Tyrosine Metabolism	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00439	Vinorelbine Action Pathway	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00337	Glutathione Synthetase Deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00143	5-Oxoprolinuria	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00501	Gamma-glutamyl-transpeptidase deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00206	Phenylketonuria	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00530	Familial lipoprotein lipase deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00529	D-glyceric acidura	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00039	Glycerolipid Metabolism	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00183	Gamma-Glutamyltransferase Deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00130	Steroidogenesis	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	1.00000000000137	1.36754982426003e-12	11	0	0	38	978
SMP00282	Streptokinase Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00185	Glutaric Aciduria Type I	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00268	Warfarin Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00276	Argatroban Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00288	Aprotinin Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00279	Ximelagatran Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00281	Anistreplase Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00545	Trifunctional protein deficiency	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00656	Dicoumarol Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00048	Nicotinate and Nicotinamide Metabolism	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00283	Tenecteplase Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00269	Acenocoumarol Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00280	Alteplase Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00277	Bivalirudin Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00271	Phenprocoumon Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00285	Reteplase Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00278	Lepirudin Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00181	Ethylmalonic Encephalopathy	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00655	Phenindione Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00586	Coagulation 	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00284	Urokinase Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00287	Tranexamic Acid Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00462	Inositol Phosphate Metabolism	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00538	Carnitine palmitoyl transferase deficiency (I)	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00270	Dicumarol Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00541	Carnitine palmitoyl transferase deficiency (II)	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00051	Fatty acid Metabolism	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00286	Aminocaproic Acid Action Pathway	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	1.00000000000288	2.8791532479116e-12	14	0	0	38	978
SMP00275	Ardeparin Action Pathway	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00494	Tyrosinemia- transient	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00031	Pentose Phosphate Pathway	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00273	Fondaparinux Action Pathway	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00344	Acute Intermittent Porphyria	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00274	Heparin Action Pathway	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00024	Porphyrin Metabolism	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00272	Enoxaparin Action Pathway	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00342	Hereditary Coproporphyria (HCP)	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00519	Ribose-5-phosphate isomerase deficiency	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00346	Porphyria Variegata (PV)	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00520	Transaldolase deficiency	1.00000000000326	3.26456844673836e-12	15	0	0	38	978
SMP00037	Lysine Degradation	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00554	Glycogenosis- Type IV. Amylopectinosis	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00186	Glutaric Aciduria Type I	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00528	Hyperlysinemia II or Saccharopinuria	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00527	Hyperlysinemia I- Familial	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00043	Galactose Metabolism	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00603	Gemcitabine Metabolism Pathway	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00553	Glycogenosis- Type III. Cori disease	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00239	Saccharopinuria/Hyperlysinemia II	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00446	Gemcitabine Action Pathway	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00719	2-aminoadipic 2-oxoadipic aciduria	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00571	Pyridoxine dependency with seizures	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00182	Galactosemia	1.00000000000352	3.52379647678776e-12	13	0	0	38	978
SMP00218	Tyrosinemia Type I	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00390	Tay-Sachs Disease	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00045	Amino Sugar Metabolism	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00498	Dopamine beta-hydroxylase deficiency	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00190	Hawkinsinuria	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00006	Tyrosine Metabolism	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00216	Sialuria or French Type Sialuria	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00217	Sialuria or French Type Sialuria	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00169	Alkaptonuria	1.0000000000038	3.80311863813382e-12	17	0	0	38	978
SMP00652	Mycophenolic Acid Metabolism Pathway	1.00000000000489	4.89095282568995e-12	16	0	0	38	978
SMP00649	Lamivudine Metabolism Pathway	1.00000000000513	5.13174284665041e-12	18	0	0	38	978
SMP00355	Mitochondrial Electron Transport Chain	1.00000000000541	5.41056557574596e-12	19	0	0	38	978
SMP00092	Rosuvastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00508	Cholesteryl ester storage disease	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00510	Mevalonic aciduria	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00387	CHILD Syndrome	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00095	Alendronate Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00107	Zoledronate Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00548	Mitochondrial complex II deficiency	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00112	Risedronate Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00119	Fluvastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00079	Ibandronate Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00057	Citric Acid Cycle	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00209	Hypercholesterolemia	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00386	Desmosterolosis	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00551	Pyruvate dehydrogenase deficiency (E2)	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00511	Wolman disease	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00023	Steroid Biosynthesis	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00099	Lovastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00509	Hyper-IgD syndrome	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00131	Atorvastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00082	Simvastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00117	Pamidronate Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00546	Congenital lactic acidosis	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00111	Cerivastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00547	Fumarase deficiency	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00089	Pravastatin Action Pathway	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00550	Pyruvate dehydrogenase deficiency (E3)	1.00000000000663	6.63132126149616e-12	21	0	0	38	978
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	1.00000000000695	6.95280919786175e-12	23	0	0	38	978
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	1.00000000000695	6.95280919786175e-12	23	0	0	38	978
SMP00172	Beta Ureidopropionase Deficiency	1.00000000000695	6.95280919786175e-12	23	0	0	38	978
SMP00046	Pyrimidine Metabolism	1.00000000000695	6.95280919786175e-12	23	0	0	38	978
SMP00178	Dihydropyrimidinase Deficiency	1.00000000000695	6.95280919786175e-12	23	0	0	38	978
SMP00025	Phospholipid Biosynthesis	1.00000000000815	8.15193876452465e-12	26	0	0	38	978
